These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 8824552)
1. Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo. Köck H; Harris MP; Anderson SC; Machemer T; Hancock W; Sutjipto S; Wills KN; Gregory RJ; Shepard HM; Westphal M; Maneval DC Int J Cancer; 1996 Sep; 67(6):808-15. PubMed ID: 8824552 [TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein. Harris MP; Sutjipto S; Wills KN; Hancock W; Cornell D; Johnson DE; Gregory RJ; Shepard HM; Maneval DC Cancer Gene Ther; 1996; 3(2):121-30. PubMed ID: 8729911 [TBL] [Abstract][Full Text] [Related]
3. Suppression of primary tumor growth and the progression to metastasis with p53 adenovirus in human prostate cancer. Eastham JA; Grafton W; Martin CM; Williams BJ J Urol; 2000 Sep; 164(3 Pt 1):814-9. PubMed ID: 10953161 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts. Nielsen LL; Dell J; Maxwell E; Armstrong L; Maneval D; Catino JJ Cancer Gene Ther; 1997; 4(2):129-38. PubMed ID: 9080122 [TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated tumor suppressor p53 gene therapy for anaplastic thyroid carcinoma in vitro and in vivo. Nagayama Y; Yokoi H; Takeda K; Hasegawa M; Nishihara E; Namba H; Yamashita S; Niwa M J Clin Endocrinol Metab; 2000 Nov; 85(11):4081-6. PubMed ID: 11095436 [TBL] [Abstract][Full Text] [Related]
6. Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cheney IW; Johnson DE; Vaillancourt MT; Avanzini J; Morimoto A; Demers GW; Wills KN; Shabram PW; Bolen JB; Tavtigian SV; Bookstein R Cancer Res; 1998 Jun; 58(11):2331-4. PubMed ID: 9622068 [TBL] [Abstract][Full Text] [Related]
7. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Liu TJ; el-Naggar AK; McDonnell TJ; Steck KD; Wang M; Taylor DL; Clayman GL Cancer Res; 1995 Jul; 55(14):3117-22. PubMed ID: 7606733 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo adenovirus-mediated p53 and p16 tumor suppressor therapy in ovarian cancer. Modesitt SC; Ramirez P; Zu Z; Bodurka-Bevers D; Gershenson D; Wolf JK Clin Cancer Res; 2001 Jun; 7(6):1765-72. PubMed ID: 11410518 [TBL] [Abstract][Full Text] [Related]
9. Cancer gene therapy mediated by CTS1, a p53 derivative: advantage over wild-type p53 in growth inhibition of human tumors overexpressing MDM2. Bougeret C; Virone-Oddos A; Adeline E; Lacroix F; Lefranc C; Ferrero L; Huet T Cancer Gene Ther; 2000 May; 7(5):789-98. PubMed ID: 10830726 [TBL] [Abstract][Full Text] [Related]
10. Delivery of the p53 tumor suppressor gene into lung cancer cells by an adenovirus/DNA complex. Nguyen DM; Wiehle SA; Koch PE; Branch C; Yen N; Roth JA; Cristiano RJ Cancer Gene Ther; 1997; 4(3):191-8. PubMed ID: 9171938 [TBL] [Abstract][Full Text] [Related]
11. Adenovirus mediated transfer of p53, GM-CSF and B7-1 suppresses growth and enhances immunogenicity of glioma cells. Pan D; Wei X; Liu M; Feng S; Tian X; Feng X; Zhang X Neurol Res; 2010 Jun; 32(5):502-9. PubMed ID: 19589203 [TBL] [Abstract][Full Text] [Related]
12. Adenovirus mediated p53 tumour suppressor gene therapy for human gastric cancer cells in vitro and in vivo. Ohashi M; Kanai F; Ueno H; Tanaka T; Tateishi K; Kawakami T; Koike Y; Ikenoue T; Shiratori Y; Hamada H; Omata M Gut; 1999 Mar; 44(3):366-71. PubMed ID: 10026322 [TBL] [Abstract][Full Text] [Related]
13. A preclinical model of minimal residual cancer in the muscle highlights challenges associated with adenovirus-mediated p53 gene transfer. Oakley R; Phillips E; Hooper R; Wilson D; Partridge M Clin Cancer Res; 2002 Jun; 8(6):1984-94. PubMed ID: 12060644 [TBL] [Abstract][Full Text] [Related]
14. Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model. Ko SC; Gotoh A; Thalmann GN; Zhau HE; Johnston DA; Zhang WW; Kao C; Chung LW Hum Gene Ther; 1996 Sep; 7(14):1683-91. PubMed ID: 8886839 [TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated transfer of p53 and p16(INK4a) results in pancreatic cancer regression in vitro and in vivo. Ghaneh P; Greenhalf W; Humphreys M; Wilson D; Zumstein L; Lemoine NR; Neoptolemos JP Gene Ther; 2001 Feb; 8(3):199-208. PubMed ID: 11313791 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of tumor cell growth by p21WAF1 adenoviral gene transfer in lung cancer. Joshi US; Chen YQ; Kalemkerian GP; Adil MR; Kraut M; Sarkar FH Cancer Gene Ther; 1998; 5(3):183-91. PubMed ID: 9622102 [TBL] [Abstract][Full Text] [Related]
17. Sensitization of rat glioblastoma multiforme to cisplatin in vivo following restoration of wild-type p53 function. Dorigo O; Turla ST; Lebedeva S; Gjerset RA J Neurosurg; 1998 Mar; 88(3):535-40. PubMed ID: 9488309 [TBL] [Abstract][Full Text] [Related]
18. Enhanced apoptotic activity of a p53 variant in tumors resistant to wild-type p53 treatment. Atencio IA; Avanzini JB; Johnson D; Neuteboom S; Vaillancourt MT; Nielsen LL; Hajian G; Sutjipto S; Sugarman BJ; Philopena J; McAllister DL; Beltran JC; Nodelman M; Ramachandra M; Wills KN Mol Ther; 2001 Jul; 4(1):5-12. PubMed ID: 11472100 [TBL] [Abstract][Full Text] [Related]
19. [Adenovirus-mediated p53 gene therapy of human laryngeal cancer]. Wang Q; Han D; Wang W Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):418-21. PubMed ID: 10920932 [TBL] [Abstract][Full Text] [Related]
20. The use of laser scanning cytometry to assess depth of penetration of adenovirus p53 gene therapy in human xenograft biopsies. Grace MJ; Xie L; Musco ML; Cui S; Gurnani M; DiGiacomo R; Chang A; Indelicato S; Syed J; Johnson R; Nielsen LL Am J Pathol; 1999 Dec; 155(6):1869-78. PubMed ID: 10595917 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]